EDC Resources

  1. Breakthrough Therapy Designation Accelerates Oncology Treatment Development 10/24/2023

    Find out how this evidence-generation company's solutions and scientific expertise enabled early and successful regulatory submission for a novel oncology therapeutic.

  2. The Role Of Technology In Improving Site Performance 5/29/2025

    Explore how clinical trial sponsors can benefit from the growing use of electronic source (eSource) technology at research sites.

  3. What Is Electronic Data Capture And How Does It Simplify Data Management? 5/6/2025

    As EDC systems continue to evolve, they streamline workflows, enhance data security, and improve patient outcomes.

  4. AI Walks Into A Room Of Data Managers. Who's The Boss Now? 8/5/2026

    What if AI could spot risks and connect fragmented data before issues arise? Learn how agentic AI may help clinical teams shift from reactive problem-solving to proactive decisions.

  5. Statistics & Data Management Group Reaches New Heights Of Clinical Trial Efficiency 4/25/2023

    Explore how a contract research organization was able to migrate from paper-based processes to cost-effectively increase efficiency, safeguard data quality, and deliver exceptional service levels to sponsors.

  6. How EDC Software Improves Patient Safety 3/10/2025

    As clinical research evolves, EDC remains a cornerstone for data accuracy, ethical compliance, and faster access to effective treatments.

  7. From Hype To Health: The Three Jobs Sword Made Its Clinical Evidence Do 8/19/2026

    A long-term strategy for turning clinical evidence into clinician trust, standard-of-care status, and payer reimbursement for digital care.

  8. eSource Purpose Is Not Just To Complete The EDC 7/7/2025

    Central eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.

  9. Vault Safety-EDC Connection 6/24/2024

    Learn how to automate the flow of Serious Adverse Event (SAE) information between data management and safety systems, enabling more timely responses by Pharmacovigilance (PV) teams.

  10. AI, Virtual Participants, and the Evolving FDA Regulatory Landscape 5/27/2026

    Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.